Michael Thomas Heffernan Insider Trading $ACTC Ocata Therapeutics, Inc.
Get free email notifications about insider trading for Michael Thomas Heffernan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Thomas Heffernan. Michael Thomas Heffernan is Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and Director in Ocata Therapeutics, Inc. ($ACTC) and Director in CORNERSTONE THERAPEUTICS INC ($CRTX) and Chairman, President and CEO in COLLEGIUM PHARMACEUTICAL, INC ($COLL) and Director in COLLEGIUM PHARMACEUTICAL, INC ($COLL) and in Akebia Therapeutics, Inc. ($AKBA) and Director in Akebia Therapeutics, Inc. ($AKBA) and Director in SYNLOGIC, INC. ($SYBX) and Director in Trevi Therapeutics, Inc. ($TRVI) and in Biohaven Pharmaceutical Holding Co Ltd. ($BHVN).
Michael Thomas Heffernan in Ocata Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Thomas Heffernan: Director
Holdings: 0 shares
Latest Transaction: Feb 11 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Michael Thomas Heffernan in Ocata Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKBA, BHVN, COLL, CRTX, KERX, ACTC, SYBX, TRVI
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | D | 8.36 | 5,000 | 41,800 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | D | 6.39 | 10,000 | 63,900 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | D | 7.94 | 100,000 | 794,000 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | D | 6.17 | 10,000 | 61,700 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | D | 6.00 | 1,250 | 7,500 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | D | 5.79 | 5,000 | 28,950 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | D | 8.00 | 3,621 | 28,968 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Sell | U | 8.50 | 31,000 | 263,500 | 0 | 31 K to 0 (-100.00 %) |
| Jan 04 2016 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | A | 8.36 | 10,000 | 83,600 | 10,000 | |
| Jan 04 2016 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Grant | A | 0.00 | 2,500 | 0 | 31,000 | 28.5 K to 31 K (+8.77 %) |
| Oct 01 2015 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Grant | A | 0.00 | 2,500 | 0 | 28,500 | 26 K to 28.5 K (+9.62 %) |
| Jul 02 2015 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Grant | A | 0.00 | 2,500 | 0 | 26,000 | 23.5 K to 26 K (+10.64 %) |
| Apr 01 2015 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Grant | A | 0.00 | 2,500 | 0 | 23,500 | 21 K to 23.5 K (+11.90 %) |
Page: 1